Skip to Main content Skip to Navigation

Loss-of-function mutations in MRAP2 are pathogenic in hyperphagic obesity with hyperglycemia and hypertension

Morgane Baron 1 Julie Maillet 1 Marlène Huyvaert 1 Aurélie Dechaume 1 Raphael Boutry 1 Hélène Loiselle 1 Emmanuelle Durand 1 Bénédicte Toussaint 1 Emmanuel Vaillant 1 Julien Philippe 1 Jérémy Thomas 2 Amjad Ghulam 2 Sylvia Franc 3, 4 Guillaume Charpentier 4, 3 Jean-Michel Borys 5 Claire Lévy-Marchal 6 Maïthe Tauber 7 Raphaël Scharfmann 8 Jacques Weill 9 Cécile Aubert 10 Julie Kerr-Conte 11 François Pattou 11 Ronan Roussel 12, 13, 14 Beverley Balkau 15 Michel Marre 13, 16 Mathilde Boissel 1 Mehdi Derhourhi 1 Stefan Gaget 1 Mickael Canouil 1 Philippe Froguel 1, 17, * Amélie Bonnefond 1, 17, *
Abstract : The G-protein-coupled receptor accessory protein MRAP2 is implicated in energy control in rodents, notably via the melanocortin-4 receptor1. Although some MRAP2 mutations have been described in people with obesity1-3, their functional consequences on adiposity remain elusive. Using large-scale sequencing of MRAP2 in 9,418 people, we identified 23 rare heterozygous variants associated with increased obesity risk in both adults and children. Functional assessment of each variant shows that loss-of-function MRAP2 variants are pathogenic for monogenic hyperphagic obesity, hyperglycemia and hypertension. This contrasts with other monogenic forms of obesity characterized by excessive hunger, including melanocortin-4 receptor deficiency, that present with low blood pressure and normal glucose tolerance4. The pleiotropic metabolic effect of loss-of-function mutations in MRAP2 might be due to the failure of different MRAP2-regulated G-protein-coupled receptors in various tissues including pancreatic islets.
Complete list of metadatas

Cited literature [41 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02439220
Contributor : Amelie Bonnefond <>
Submitted on : Tuesday, January 14, 2020 - 3:06:25 PM
Last modification on : Friday, March 27, 2020 - 2:48:50 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : 2020-04-30

Please log in to resquest access to the document

Identifiers

Citation

Morgane Baron, Julie Maillet, Marlène Huyvaert, Aurélie Dechaume, Raphael Boutry, et al.. Loss-of-function mutations in MRAP2 are pathogenic in hyperphagic obesity with hyperglycemia and hypertension. Nature Medicine, Nature Publishing Group, 2019, 25 (11), pp.1733-1738. ⟨10.1038/s41591-019-0622-0⟩. ⟨inserm-02439220⟩

Share

Metrics

Record views

92